相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complete Remission of Protein-Losing Gastroenteropathy Associated With Sjogren's Syndrome by B Cell-Targeted Therapy With Rituximab
Yoshika Uraoka et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
B-cell-depleting Therapy in Systemic Lupus Erythematosus
Manuel Ramos-Casals et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry
A. Mekinian et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren's syndrome treated with rituximab
P. M. Meiners et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: Results of a prospective multicenter French cohort study
Valerie Devauchelle-Pensec et al.
ARTHRITIS AND RHEUMATISM (2012)
B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome
Pierre Youinou et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjogren's syndrome
Ying-Ting Chen et al.
LABORATORY INVESTIGATION (2012)
CONNECTIVE TISSUE DISEASES Trial of SLE therapies in real-world settings
Manuel Ramos-Casals et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Topical and systemic medications for the treatment of primary Sjogren's syndrome
Manuel Ramos-Casals et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjogren Syndrome
Michael Voulgarelis et al.
MEDICINE (2012)
Interleukin-1 Inhibition and Fatigue in Primary Sjogren's Syndrome - A Double Blind, Randomised Clinical Trial
Katrine Braekke Norheim et al.
PLOS ONE (2012)
Fatigue and depression predict physician visits and work disability in women with primary Sjogren's syndrome: results from a cohort study
Gisela Westhoff et al.
RHEUMATOLOGY (2012)
Interstitial cystitis: a rare manifestation of primary Sjogren's syndrome, successfully treated with low dose cyclosporine
Hakan Emmungil et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Primary Sjogren's syndrome in Moroccan patients: characteristics, fatigue and quality of life
Yousra Ibn Yacoub et al.
RHEUMATOLOGY INTERNATIONAL (2012)
PRACTICE POINTER Primary Sjogren syndrome
Manuel Ramos-Casals et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Dramatic Reversal of Lymphocytic Interstitial Pneumonitis in Sjogren's Syndrome With Rituximab
Morris A. Swartz et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders
Mark Ballow
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome: A Retrospective Clinical Study
Rodney P. E. Pollard et al.
JOURNAL OF RHEUMATOLOGY (2011)
The role of antimalarial agents in the treatment of SLE and lupus nephritis
Senq-J Lee et al.
NATURE REVIEWS NEPHROLOGY (2011)
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
Pablo Engel et al.
PHARMACOLOGICAL REVIEWS (2011)
Experience of Intravenous Immunoglobulin Therapy in Neuropathy Associated With Primary Sjogren's Syndrome: A National Multicentric Retrospective Study
Stephanie Rist et al.
ARTHRITIS CARE & RESEARCH (2011)
Interleukin-1 as a Phenotypic Immunomodulator in Keratinizing Squamous Metaplasia of the Ocular Surface in Sjogren's Syndrome
Ying-Ting Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome A Randomized, Double-Blind, Placebo-Controlled Trial
J. M. Meijer et al.
ARTHRITIS AND RHEUMATISM (2010)
Failure of Intravenous Immunoglobulin to Prevent Congenital Heart Block Findings of a Multicenter, Prospective, Observational Study
C. N. Pisoni et al.
ARTHRITIS AND RHEUMATISM (2010)
Evaluation of Fetuses in a Study of Intravenous Immunoglobulin as Preventive Therapy for Congenital Heart Block Results of a Multicenter, Prospective, Open-Label Clinical Trial
Deborah M. Friedman et al.
ARTHRITIS AND RHEUMATISM (2010)
Pathogenesis of Sjogren's syndrome and therapeutic consequences
Xavier Mariette et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Treatment of Primary Sjogren Syndrome A Systematic Review
Manuel Ramos-Casals et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael P. Cancro et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Successful treatment of relapsing autoimmune pancreatitis in primary Sjogren's syndrome with Rituximab: report of a case and review of the literature
Juan C. Rueda et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
S. Dass et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjogren's syndrome
D. Sanchez-Cano et al.
LUPUS (2008)
Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjogren's syndrome
Pascal Sève et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Sjogren keratoconjunctivitis sicca treated with rituximab
Luis Fernando Zapata et al.
CORNEA (2007)
Immunoglobulin-responsive dysautonomia in Sjogren's syndrome
Yusuf A. Rajabally et al.
JOURNAL OF NEUROLOGY (2007)
Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20)
Valerie Devauchelle-Pensec et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Emerging biological therapies in primary Sjogren's syndrome
M. Ramos-Casals et al.
RHEUMATOLOGY (2007)
Successful treatment of Sjogren's syndrome with rituximab
Z. Touma et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren's syndrome: an open-label phase I/II study
Serge D. Steinfeld et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years
LD Barber et al.
OPHTHALMOLOGY (2005)
Rituximab treatment in patients with primary Sjogren's syndrome
J Pijpe et al.
ARTHRITIS AND RHEUMATISM (2005)
Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab
K Ahmadi-Simab et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
JE Gottenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Inefficacy of infliximab in primary Sjogren's syndrome -: Results of the randomized, controlled trial of Remicade in primary Sjogren's syndrome (TRIPSS)
X Mariette et al.
ARTHRITIS AND RHEUMATISM (2004)
Severe interstitial cystitis associated with Sjogren's syndrome
S Shibata et al.
INTERNAL MEDICINE (2004)
Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine - A randomized, placebo-controlled, dose-adjustment study
AS Papas et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2004)
Etanercept in Sjogren's syndrome - A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
V Sankar et al.
ARTHRITIS AND RHEUMATISM (2004)
Clinical manifestations and early diagnosis of Sjogren syndrome
SS Kassan et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Treatment of primary Sjogren's syndrome with low-dose human interferon alfa administered by the oromucosal route: Combined phase III results
MJ Cummins et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjogren's syndrome
AV Khurshudian
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS (2003)
Agranulocytosis in Sjogren's syndrome: Two case reports and analysis of 11 additional reported cases
J Friedman et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Motor dominant neuropathy in Sjogren's syndrome: Report of two cases
H Mochizuki et al.
INTERNAL MEDICINE (2002)
Use of muscarinic agonists in the treatment of Sjogren's syndrome
RI Fox et al.
CLINICAL IMMUNOLOGY (2001)
Muscarinic receptor agonists and antagonists
KJ Broadley et al.
MOLECULES (2001)
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
K Sall et al.
OPHTHALMOLOGY (2000)
分享论文
